Pavelka K - Search Results

1

GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes.

Nakayama A, Nakaoka H, Yamamoto K, Sakiyama M, Shaukat A, Toyoda Y, Okada Y, Kamatani Y, Nakamura T, Takada T, Inoue K, Yasujima T, Yuasa H, Shirahama Y, Nakashima H, Shimizu S, Higashino T, Kawamura Y, Ogata H, Kawaguchi M, Ohkawa Y, Danjoh I, Tokumasu A, Ooyama K, Ito T, Kondo T, Wakai K, Stiburkova B, Pavelka K, Stamp LK, Dalbeth N; Eurogout Consortium; Sakurai Y, Suzuki H, Hosoyamada M, Fujimori S, Yokoo T, Hosoya T, Inoue I, Takahashi A, Kubo M, Ooyama H, Shimizu T, Ichida K, Shinomiya N, Merriman TR, Matsuo H; Eurogout Consortium. Nakayama A, et al. Among authors: pavelka k. Ann Rheum Dis. 2017 May;76(5):869-877. doi: 10.1136/annrheumdis-2016-209632. Epub 2016 Nov 29. Ann Rheum Dis. 2017. PMID: 27899376 Free PMC article.

2

COL6A1, the candidate gene for ossification of the posterior longitudinal ligament, is associated with diffuse idiopathic skeletal hyperostosis in Japanese.

Tsukahara S, Miyazawa N, Akagawa H, Forejtova S, Pavelka K, Tanaka T, Toh S, Tajima A, Akiyama I, Inoue I. Tsukahara S, et al. Among authors: pavelka k. Spine (Phila Pa 1976). 2005 Oct 15;30(20):2321-4. doi: 10.1097/01.brs.0000182318.47343.6d. Spine (Phila Pa 1976). 2005. PMID: 16227896

3

Complex analysis of urate transporters SLC2A9, SLC22A12 and functional characterization of non-synonymous allelic variants of GLUT9 in the Czech population: no evidence of effect on hyperuricemia and gout.

Hurba O, Mancikova A, Krylov V, Pavlikova M, Pavelka K, Stibůrková B. Hurba O, et al. Among authors: pavelka k. PLoS One. 2014 Sep 30;9(9):e107902. doi: 10.1371/journal.pone.0107902. eCollection 2014. PLoS One. 2014. PMID: 25268603 Free PMC article.

4

Hyperuricemia and gout due to deficiency of hypoxanthine-guanine phosphoribosyltransferase in female carriers: New insight to differential diagnosis.

Kostalova E, Pavelka K, Vlaskova H, Musalkova D, Stiburkova B. Kostalova E, et al. Among authors: pavelka k. Clin Chim Acta. 2015 Feb 2;440:214-7. doi: 10.1016/j.cca.2014.11.026. Epub 2014 Dec 1. Clin Chim Acta. 2015. PMID: 25476133

5

Novel dysfunctional variant in ABCG2 as a cause of severe tophaceous gout: biochemical, molecular genetics and functional analysis.

Stiburkova B, Miyata H, Závada J, Tomčík M, Pavelka K, Storkanova G, Toyoda Y, Takada T, Suzuki H. Stiburkova B, et al. Among authors: pavelka k. Rheumatology (Oxford). 2016 Jan;55(1):191-4. doi: 10.1093/rheumatology/kev350. Epub 2015 Sep 30. Rheumatology (Oxford). 2016. PMID: 26428519 No abstract available.

6

Functional non-synonymous variants of ABCG2 and gout risk.

Stiburkova B, Pavelcova K, Zavada J, Petru L, Simek P, Cepek P, Pavlikova M, Matsuo H, Merriman TR, Pavelka K. Stiburkova B, et al. Among authors: pavelka k. Rheumatology (Oxford). 2017 Nov 1;56(11):1982-1992. doi: 10.1093/rheumatology/kex295. Rheumatology (Oxford). 2017. PMID: 28968913

7

The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients.

Stiburkova B, Pavelcova K, Pavlikova M, Ješina P, Pavelka K. Stiburkova B, et al. Among authors: pavelka k. Arthritis Res Ther. 2019 Mar 20;21(1):77. doi: 10.1186/s13075-019-1860-8. Arthritis Res Ther. 2019. PMID: 30894219 Free PMC article.

8

Functional Characterization of Clinically-Relevant Rare Variants in ABCG2 Identified in a Gout and Hyperuricemia Cohort.

Toyoda Y, Mančíková A, Krylov V, Morimoto K, Pavelcová K, Bohatá J, Pavelka K, Pavlíková M, Suzuki H, Matsuo H, Takada T, Stiburkova B. Toyoda Y, et al. Among authors: pavelka k. Cells. 2019 Apr 18;8(4):363. doi: 10.3390/cells8040363. Cells. 2019. PMID: 31003562 Free PMC article.

9

Interaction of the p.Q141K Variant of the ABCG2 Gene with Clinical Data and Cytokine Levels in Primary Hyperuricemia and Gout.

Horváthová V, Bohatá J, Pavlíková M, Pavelcová K, Pavelka K, Šenolt L, Stibůrková B. Horváthová V, et al. Among authors: pavelka k. J Clin Med. 2019 Nov 14;8(11):1965. doi: 10.3390/jcm8111965. J Clin Med. 2019. PMID: 31739430 Free PMC article.

10

Evaluation of the Influence of Genetic Variants of SLC2A9 (GLUT9) and SLC22A12 (URAT1) on the Development of Hyperuricemia and Gout.

Pavelcova K, Bohata J, Pavlikova M, Bubenikova E, Pavelka K, Stiburkova B. Pavelcova K, et al. Among authors: pavelka k. J Clin Med. 2020 Aug 4;9(8):2510. doi: 10.3390/jcm9082510. J Clin Med. 2020. PMID: 32759716 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

484 results

Search Page